spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Alizé Pharma 

 HSMN NewsFeed - 6 Apr 2018
Impax Launches a Generic Version of Estrace(R) Cream (estradiol vaginal cream, USP, 0.01%)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 8 Dec 2017
Impax Receives Tentative FDA Approval of Generic Coreg CR(R) (Carvedilol Phosphate) Extended-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Apr 2017
Impax Announces FDA Approval and Launch of a Generic Version of Vytorin(R) (Ezetimibe/Simvastatin Tablets)
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 13 Apr 2016
Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 17 Feb 2016
Impax Receives FDA Approval for Generic Version of Adderall XR(R) (mixed salts of a single-entity amphetamine product) Capsules, CII
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Feb 2016
Impax Receives Tentative FDA Approval for Generic Version of Vytorin(R) (ezetimibe and simvastatin) Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 15 Jan 2016
Impax Receives Approval of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Sep 2015
Impax Receives FDA Approval for Generic Version of Mestinon(R) Timespan(R) Tablets, 180 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Jan 2014
Impax and DURECT Sign a $63 Million Agreement to Develop and Commercialize DURECT’s ELADUR(R) Pain Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 3 Dec 2013
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 Nov 2013
Impax Laboratories Launches Generic Solaraze(R) (Diclofenac Sodium Gel, 3%)
Biopharmaceuticals Generics Dermatology Product Launch
 HSMN NewsFeed - 25 Jun 2013
Dr. Larry Hsu, Impax Laboratories President and Chief Executive Officer, to Retire
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2013
Impax and Shire Settle Litigation Concerning Supply of Authorized Generic Adderall XR(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to CONCERTA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Sep 2012
Impax Laboratories Announces Settlement of Litigation Relating to RENVELA(R) and RENAGEL(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 Feb 2012
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Feb 2011
Impax Laboratories Receives Final FDA Approval for Generic Adoxa(R) 150 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 16 Dec 2010
GlaxoSmithKline and Impax Pharmaceuticals Enter Global Agreement to Develop and Commercialize a late stage compound for Parkinson’s Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Nov 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Cymbalta(R) Delayed-Release 20, 30 and 60 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Oct 2010
Infinity Announces That Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Ltd. Exercise Rights to Develop and Commercialize Infinity's FAAH Pain Program Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2010
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 14 May 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Opana(R) ER 5, 7.5, 10, 15, 20, 30 and 40 mg Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Apr 2010
Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Mar 2010
Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 12 Jan 2010
Proteus Biomedical Announces License and Collaboration Agreement for Sensor-Based Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Oct 2009
Impax Laboratories Receives Tentative FDA Approval for Generic FLOMAX(R) 0.4mg Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 19 May 2009
Impax Receives FDA Approval for Generic Precose Tablets, 25 mg, 50 mg and 100 mg
Biopharmaceuticals Generics Endocrinology
 HSMN NewsFeed - 23 Jan 2009
IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Jan 2009
Impax Confirms Patent Challenge Relating to Amrix (R) Extended-Release Capsules, 15mg and 30mg
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Nov 2008
Impax Sued Based on Anda for Generic Cymbalta(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 3 Sep 2008
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2008
Impax Announces Final Settlement of Generic Effexor Xr Patent Suit
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Jul 2008
Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2008
IMPAX Establishes Branded Products Division with Appointments of Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2008
IMPAX Comments on Lawsuit Related to Generic Version of Detrol LA(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 30 Jan 2008
IMPAX Receives FDA Non-Approvable Letter for Vadova(R); Company Considering Options
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Jan 2008
IMPAX Announces Lawsuit Related to Generic Version of SOLODYN(R)
Biopharmaceuticals Generics Dermatology
 HSMN NewsFeed - 19 Nov 2007
IMPAX Comments on Lawsuit Related to Generic Version of Opana(R) ER
Biopharmaceuticals Litigation
 HSMN NewsFeed - 18 Oct 2007
IMPAX Announces Tentative Approval of Generic Effexor XR(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Jun 2007
IMPAX Announces Lawsuit Related to Generic Version of Depakote ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Jun 2007
IMPAX Announces Decision on Generic Prilosec(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 May 2007
IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Apr 2007
IMPAX Announces FDA Approval of Generic Corzide
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
Biopharmaceuticals Generics Litigation Licensing
 HSMN NewsFeed - 5 Mar 2007
IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Dec 2006
IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Dec 2006
New Atlanta-Based Pharmaceutical Company Focuses on Central Nervous System
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Nov 2006
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 3 Nov 2006
IMPAX Receives FDA Approval for Generic Versions of Urecholine(R) Tablets
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 26 Oct 2006
IMPAX Receives FDA Approval for Generic Version of Colestid(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Oct 2006
IMPAX Announces Dismissal of Lawsuit Related to Generic Concerta(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2006
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Aug 2006
IMPAX Names Larry Hsu as CEO Effective October 1, 2006
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2006
IMPAX Announces the Launch of IMPAX Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2006
IMPAX Settles Solvay Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 May 2006
IMPAX Receives FDA Approval for Generic Version of Colestid(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Apr 2006
IMPAX Receives FDA Approval for Generic Version of SALAGEN(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Mar 2006
GlaxoSmithKline and Pharmacopeia Enter Into Drug Discovery and Development Alliance
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2006
IMPAX Receives FDA Non-Approvable Letter for Vadova
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 44

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 44 additional stories matching:
Alizé Pharma
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.